Material Safety Data Sheet
VAMAC G ethylene acrylic elastomer
Version 3.3 Revision Date 07/10/2013 Ref. 130000022224
This SDS adheres to the standards and regulatory requirements of the United States and may not meet the regulatory requirements in other countries. SECTION 1. PRODUCT AND COMPANY IDENTIFICATION Product name MSDS Number Manufacturer : : : VAMAC G ethylene acrylic elastomer 130000022224 DuPont 1007 Market Street Wilmington, DE 19898 1-800-441-7515 (outside the U.S. 1-302-774-1000) 1-800-441-3637 (outside the U.S. 1-302-774-1139) CHEMTREC: +1-800-424-9300 (outside the U.S. +1-703-527-3887)
Product Information Medical Emergency Transport Emergency
: : :
SECTION 2. HAZARDS IDENTIFICATION Potential Health Effects Exposure to off gases may cause dermatitis (reddening of the skin)., Irritation Skin Methyl acrylate : Causes skin irritation. May cause: Irritation with discomfort or pain, redness or rash, itching, swelling, blisters, cracking or peeling of skin, severe effects after repeated or prolonged exposure. May cause sensitisation by skin contact. May cause allergic skin reaction with itching, rash, or swelling. Toxic in contact with skin. Causes damage to the kidneys/ liver/ eyes/ brain/ respiratory system/ central nervous system in contact with skin. Impairment of vision, Blindness. May cause skin irritation. May cause: Discomfort, itching, redness, or swelling.
Methanol
Eyes
1 / 11
Material Safety Data Sheet
VAMAC G ethylene acrylic elastomer
Version 3.3 Revision Date 07/10/2013 Ref. 130000022224
Methyl acrylate
Causes eye irritation. May cause permanent eye injury. Risk of serious damage to eyes. May cause eye irritation. May cause: Tearing, redness, or discomfort. Harmful by inhalation. Causes respiratory tract irritation. May cause: Cough, sneezing, runny nose, sore throat, or shortness of breath. Toxic by inhalation. Causes damage to the kidneys/ liver/ eyes/ brain/ respiratory system/ central nervous system if inhaled. Impairment of vision, Blindness.
Methanol
Inhalation Methyl acrylate
Methanol
Ingestion Methyl acrylate Methanol
: :
Ingestion may cause gastrointestinal irritation, nausea, vomiting and diarrhoea. Toxic if swallowed. Causes damage to the kidneys/ liver/ eyes/ brain/ digestive system/ central nervous system if swallowed. Impairment of vision, Blindness. Respiratory Tract Central nervous system Eyes
Target Organ Methyl acrylate Methanol
: :
Carcinogenicity None of the components present in this material at concentrations equal to or greater than 0.1% are listed by IARC, NTP, or OSHA, as a carcinogen.
SECTION 3. COMPOSITION/INFORMATION ON INGREDIENTS Component CAS-No. Concentration
2 / 11
Material Safety Data Sheet
VAMAC G ethylene acrylic elastomer
Version 3.3 Revision Date 07/10/2013 Ref. 130000022224
Ethylene Acrylate Copolymer
>99%
Methyl acrylate
96-33-3
<0.3 %
Methanol
67-56-1
<0.1 %
SECTION 4. FIRST AID MEASURES Skin contact : In case of contact, immediately flush eyes or skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Wash contaminated clothing before reuse. Cool skin rapidly with cold water after contact with molten material. Do not attempt to remove material from the skin. Obtain medical treatment for thermal burn. : In case of contact, immediately flush eyes with plenty of water for at least 15 minutes. Call a physician. : If inhaled, remove to fresh air. Get medical attention. Call a physician. If not breathing, give artificial respiration. : Not a probable route of exposure. However, in case of accidental ingestion, call a physician.
Eye contact
Inhalation Ingestion
SECTION 5. FIREFIGHTING MEASURES Flammable Properties Flash point : ca. 212.5 C (414.5 F) at 1,016 hPa closed cup Method : Setaflash closed cup - SCC
Fire and Explosion Hazard
: Hazardous combustion products Carbon dioxide (CO2) hydrocarbon oxidation products Alcohols Ketones Aldehydes Esters carboxylic acids Oxides of phosphorus
3 / 11
Material Safety Data Sheet
VAMAC G ethylene acrylic elastomer
Version 3.3 Revision Date 07/10/2013 Ref. 130000022224
Hazardous combustion products Suitable extinguishing media Firefighting Instructions
Acrolein, Phosphonic acid : Water, Foam, Dry chemical, Carbon dioxide (CO2) : Wear self-contained breathing apparatus and protective suit. Evacuate personnel and keep upwind of fire. The solid polymer can only be burned with difficulty.
SECTION 6. ACCIDENTAL RELEASE MEASURES NOTE: Review FIRE FIGHTING MEASURES and HANDLING (PERSONNEL) sections before proceeding with cleanup. Use appropriate PERSONAL PROTECTIVE EQUIPMENT during clean-up. Spill Cleanup Accidental Release Measures : Shovel or sweep up. : Do not discharge to streams, ponds, lakes or sewers.
SECTION 7. HANDLING AND STORAGE Handling (Personnel) : When opening containers, avoid breathing vapours that may be emanating. Do not breathe vapours or fumes that may be evolved during processing. Before using, read the product bulletin. : Keep containers tightly closed in a cool, well-ventilated place. Storage of multiple pallets in unventilated area may cause acrylate concentrations to exceed specified limits.
Storage
SECTION 8. EXPOSURE CONTROLS/PERSONAL PROTECTION Engineering controls : When hot processing this material, use local and/or general exhaust ventilation to maintain the concentration of vapors and fumes below exposure limits. See Bulletin "Proper Use of Local Exhaust Ventilation During Processing of Plastics". Use sufficient ventilation to keep employee exposure below recommended limits. 4 / 11
Material Safety Data Sheet
VAMAC G ethylene acrylic elastomer
Version 3.3 Revision Date 07/10/2013 Ref. 130000022224
Personal protective equipment Respiratory protection
: A respiratory protection program that meets country requirements must be followed whenever workplace conditions warrant respirator use. Consult the respirator manufacturer to determine the appropriate type of equipment for a given application. Observe respirator use limitations specified by the manufacturer. Consult the OSHA respiratory protection information located at 29CFR 1910.134. : Material: Protective gloves
Hand protection
Eye protection
: Wear safety glasses with side shields. Wear tightly fitting chemical splash goggles and face shield when possibility exists for eye and face contact due to spattering or splashing of molten material. : Where there is potential for skin contact, have available and wear as appropriate, impervious gloves, apron, pants, jacket, hood and boots. If there is a potential for contact with hot/molten material wear heat resistant clothing and footwear.
Skin and body protection
Exposure Guidelines Exposure Limit Values
Methyl acrylate PEL:
(OSHA)
10 ppm 35 mg/m3 Skin designation
8 hr. TWA
TLV
(ACGIH)
2 ppm TWA Skin designation
AEL *
(DUPONT)
5 ppm
15 minute TWA, Skin
Skin designation
Methanol PEL:
(OSHA)
200 ppm 5 / 11
260 mg/m3
8 hr. TWA
Material Safety Data Sheet
VAMAC G ethylene acrylic elastomer
Version 3.3 Revision Date 07/10/2013 Ref. 130000022224
TLV
(ACGIH)
250 ppm Skin designation
STEL
TLV AEL *
(ACGIH) (DUPONT)
200 ppm 200 ppm Skin designation
TWA 8 & 12 hr. TWA, Skin
Dust (inhalable and respirable fraction) PEL: (OSHA) PEL: TLV TLV Biological Exposure Indices Methanol BEI (ACGIH) (OSHA) (ACGIH) (ACGIH)
5 mg/m3 15 mg/m3 10 mg/m3 3 mg/m3
8 hr. TWA Respirable fraction. 8 hr. TWA Total dust. TWA Inhalable particles. TWA Respirable particles.
15 mg/l Methanol/Urine Sampling time: End of shift.
* AEL is DuPont's Acceptable Exposure Limit. Where governmentally imposed occupational exposure limits which are lower than the AEL are in effect, such limits shall take precedence.
SECTION 9. PHYSICAL AND CHEMICAL PROPERTIES Form Color Odor Specific gravity Water solubility : : : : : bales clear acrylic-like >1 insoluble
6 / 11
Material Safety Data Sheet
VAMAC G ethylene acrylic elastomer
Version 3.3 Revision Date 07/10/2013 Ref. 130000022224
SECTION 10. STABILITY AND REACTIVITY Stability Conditions to avoid Incompatibility Hazardous decomposition products : Stable at normal temperatures and storage conditions. C (> 540 F) : Temperature > 282 Long hold up times. Decomposes on heating. : None reasonably foreseeable. : Decomposition is a function of both processing temperature and time at that temperature. Decomposition can occur below the recommended processing temperature limit. At temperatures above the "conditions to avoid" temperature, thermal decomposition of the resin becomes rapid. Hazardous decomposition products: Alcohols, Acrolein, phosphorous oxides, Ketones, Aldehydes, Esters, Organic acids, Carboxylic acid , Phosphonic acid : Polymerization will not occur.
Hazardous reactions
SECTION 11. TOXICOLOGICAL INFORMATION Ethylene Acrylate Copolymer Eye irritation : animals (unspecified species) non-irritant
Methyl acrylate Dermal LD50 Oral LD50 Inhalation 4 h LC50
: : :
1,250 mg/kg , rabbit 768 mg/kg , rat 6.5 mg/l , rat Target Organs: Respiratory Tract Respiratory tract irritation Severe skin irritation, rabbit Severe eye irritation, rabbit 7 / 11
Skin irritation Eye irritation
: :
Material Safety Data Sheet
VAMAC G ethylene acrylic elastomer
Version 3.3 Revision Date 07/10/2013 Ref. 130000022224
Skin sensitization Repeated dose toxicity
: :
Causes sensitisation., mouse Inhalation rat Respiratory tract irritation
Carcinogenicity Mutagenicity
: :
Animal testing did not show any carcinogenic effects. Did not cause genetic damage in animals. Genetic damage in cultured mammalian cells was observed in some laboratory tests but not in others. Did not cause genetic damage in cultured bacterial cells. Animal testing showed no reproductive toxicity. Animal testing showed effects on embryo-fetal development at levels equal to or above those causing maternal toxicity. 300 mg/kg animals (unspecified species) Target Organs: Central nervous system Central nervous system effects narcosis eye effects 3 mg/l animals (unspecified species) Target Organs: Central nervous system Central nervous system effects narcosis eye effects Slight or no skin irritation, rabbit slight irritation, rabbit Did not cause sensitisation on laboratory animals., guinea pig 8 / 11
Reproductive toxicity Teratogenicity Methanol Dermal Acute toxicity estimate Dermal
: :
: :
Inhalation Acute toxicity estimate Inhalation
: :
Skin irritation Eye irritation Skin sensitization
: : :
Material Safety Data Sheet
VAMAC G ethylene acrylic elastomer
Version 3.3 Revision Date 07/10/2013 Ref. 130000022224
Carcinogenicity Mutagenicity
: :
Overall weight of evidence indicates that the substance is not carcinogenic. Overall weight of evidence indicates that the substance is not mutagenic. Did not cause genetic damage in animals. Genetic damage in cultured mammalian cells was observed in some laboratory tests but not in others. Genetic damage in cultured bacterial cells was observed in some laboratory tests but not in others. Evidence suggests the substance is not a reproductive toxin in animals. Evidence suggests the substance is not a developmental toxin in animals.
Reproductive toxicity Teratogenicity
: :
SECTION 12. ECOLOGICAL INFORMATION Aquatic Toxicity Methyl acrylate 96 h LC50 72 h ErC50 72 h EbC50 48 h EC50 21 d Methanol 96 h LC50 96 h LC50 48 h EC50 : : : Pimephales promelas (fathead minnow) 28,100 mg/l Selenastrum capricornutum (green algae) 22,000 mg/l Daphnia > 10,000 mg/l 9 / 11
: : : : :
Oncorhynchus mykiss (rainbow trout) 3.4 mg/l Pseudokirchneriella subcapitata 3.55 mg/l Pseudokirchneriella subcapitata (green algae) 2.02 mg/l Daphnia magna (Water flea) 2.6 mg/l NOEC Daphnia 0.19 mg/l Information given is based on data obtained from similar substances.
Material Safety Data Sheet
VAMAC G ethylene acrylic elastomer
Version 3.3 Revision Date 07/10/2013 Ref. 130000022224
Environmental Fate Methyl acrylate Biodegradability Bioaccumulation Methanol Biodegradability Bioaccumulation Additional ecological information : : : Readily biodegradable. Bioaccumulation is unlikely. There is no data available for this product. Toxicity is expected to be low based on insolubility in water. : : Readily biodegradable. Bioaccumulation is unlikely.
SECTION 13. DISPOSAL CONSIDERATIONS Waste Disposal : Preferred options for disposal are recycling, incineration with energy recovery, and landfill. The high fuel value of this product makes incineration very desirable for material that cannot be recycled. Treatment, storage, transportation, and disposal must be in accordance with applicable federal, state/provincial, and local regulations.
SECTION 14. TRANSPORT INFORMATION
Not classified as dangerous in the meaning of transport regulations.
SECTION 15. REGULATORY INFORMATION TSCA Status SARA 313 Regulated Chemical(s) : In compliance with TSCA Inventory requirements for commercial purposes. : SARA 313: This material does not contain any chemical components with known CAS numbers that exceed the threshold (De Minimis) reporting levels established by SARA Title III, Section 313. 10 / 11
DuPont Vamac
Safe Handling and Processing of Vamac and Compounds made from Vamac
Technical Information Rev. 3, February 2012
Read and understand the Material Safety Data Sheet (M/SDS) before using DuPont Vamac ethylene acrylic elastomers. Toxicity Information Related to the Handling and Processing of Vamac
Vamac ethylene acrylic elastomers are made from ethylene, methyl acrylate and a cure site monomer. Normally, they are blended with typical rubber ingredients and then processed and cured. There are many different compounds made from Vamac elastomers, and they use various mixing and processing conditions and curing processes. This literature reviews the safe handling of Vamac elastomers and gives a general overview of handling compounds based on Vamac elastomers.
Vamac Polymer and Methyl Acrylate Monomer
Vamac elastomers or polymers fall into two general categories. The majority of them are terpolymers made from ethylene, methyl acrylate and a cure site monomer. These terpolymers are normally cured with diamines. The other category of Vamac polymers is dipolymers which are made from ethylene and methyl acrylate. Dipolymers are normally cured with organic peroxides. All Vamac elastomers contain some residual methyl acrylate monomer (CAS number 96-33-3). A typical level of residual methyl acrylate monomer is 0.15% by weight (1500 ppm). Most of this monomer is lost during the processing and curing steps and very little is found in the finished parts. Methyl acrylate exposure in the workplace where Vamac elastomers are processed can be controlled within the desired limits by the use of proper ventilation (for example local exhaust ventilation). High vapor concentrations can cause irritation to eyes, nose, throat and lungs. Overexposure can lead to pulmonary edema and possible injury to liver and kidneys. Methyl acrylate can be absorbed through the skin. Methyl acrylate is regulated as an air contaminant in the United States under the Occupational Safety and Health Act per 29 CFR 1910.1000 Air Contaminants, with an 8-hour time weighted average (TWA) permissible exposure limit (PEL) of 10 ppm (skin)*. The American Conference of Governmental Industrial Hygienists (2011 edition) sets an 8-hour TWA threshold limit value (TLV) of 2 ppm (skin). DuPont has established a 15-minute TWA of 5 ppm (skin) as an acceptable exposure limit (AEL). DuPont applies this limit to its manufacturing and laboratory operations for Vamac. Other regions of the world may have different allowable occupational airborne levels of methyl acrylate monomer. Please consult the local regulations.
*A skin notation indicates that dermal exposure can be a significant contributor to the overall exposure (i.e., in addition to inhalation exposure) and subsequent internal doses in the body.
The odor threshold for methyl acrylate is approximately 14 parts per billion (ppb). Therefore, sense of smell is not a reliable indicator of the methyl acrylate airborne concentration in an area. Repeated exposure can desensitize the nose. Adequate control of exposure to methyl acrylate and other decomposition products from processing can be realized by proper ventilation. The ventilation requirements of each plant location and operation may differ sufficiently to warrant individual methyl acrylate monitoring of each area. Areas where DuPont Vamac is stored should be assessed as well as the processing areas. Actual concentration of methyl acrylate in air can be determined by using a gas analyzer. The DuPont brochure on Proper Use of Ventilation During Processing of Plastics has some good suggestions on how to limit worker exposure to air borne chemicals. Please contact your local DuPont representative if you would like a copy.
Compounds made from Vamac Handling Precautions while Processing
There are many possible steps used to process compounds made from Vamac including mixing, molding, de-molding, extrusion, curing, post curing, etc. During the processing steps, some gaseous byproducts will be vaporized into the air in the immediate work area. The composition of these vapors will depend on the compounding ingredients added to the compound along with the process conditions such as temperature and pressure. Many of the rubber compounding ingredients have a substantial vapor pressure at elevated temperatures and can contribute significantly to the amount of volatiles. Therefore, only general guidelines for handling precautions can be provided. As mentioned previously, most of the Vamac polymers used today are based on terpolymers (i.e. Vamac G and Vamac GLS) and these are cured with diamines. The following discussion relates to terpolymers. Dipolymers are cured with peroxides and will have different volatiles. A typical compound made from a Vamac terpolymer may have a formulation that has the ranges listed below: 100 parts polymer 50 to 80 parts carbon black 0 to 20 parts of a plasticizer 1 to 3 parts of a release package 1 to 3 parts of an anti-oxidant 1 to 2 parts of a curative usually hexamethylene diamine carbamate (HMDC) 1 to 5 parts of an accelerator diorthotolyl guanidine (DOTG) or Diazobicyclo undecene (DBU) The compound will usually be mixed on an internal mixer at about 100 C (212 F) and then sheeted off on a roll mill. It will then either be extruded into a hose or molded. Typical process temperatures for extruding hoses are about 60 to 90C (140 to 194F). For molding, the temperature can be around 180C (356F). For most of the molding cycle the mold is closed and under pressure (limited volatiles) but at the end of the molding cycle the mold is open to atmospheric pressure and this is when the volatiles concentration will be the highest. In the final processing step a hose will be cured in an autoclave at about 175 C (347 F) under pressure. Molded parts are usually post cured for several hours at about 175 C (347 F) at ambient pressure. During the curing step the HMDC curative will break down to hexamethylene diamine (HMDA) and carbon dioxide (CO2). Also during the cure step the diamine/cure site reaction will generate water and ethanol. The weight loss from these volatiles for a compound with 1.5 phr of HMDC and a total of 200 parts will be: 0.21% weight loss from CO2 produced when HMDC is converted to HMDA 0.17% weight loss from water generated during cure 0.43% weight loss from ethanol generated during cure The total volatiles from the cure system (CO2, water and ethanol) are about 0.8% by weight for a typical compound. The amount and nature of the other volatiles encountered during the vulcanization of an elastomer are difficult to assess since chemical side reactions can take place. These reactions and the volatiles
2
generated depend on the specific compound formulations and the type of curing system. The concentration of volatiles in a given area will depend on many factors including the length of the heating cycle, the size of the part, the access to the atmosphere, the size of the area and the degree of air circulation. The off-gases generated in the curing of a typical compound made from a Vamac terpolymer are shown in Table 1. These values are shown for information only and should not be used to predict concentrations of off-gases in a given work area. If there are any questions, it is suggested that processors of compounds made from Vamac monitor for possible off-gases and measure the actual concentrations in the workplace.
Table 1 Off-Gases Generated During Isothermal Heating 20 minutes at 177 C Off-Gas Concentrations are Given in Weight Percent of Compound
Ingredient Vamac G Vanfre VAM Armeen 18D Stearic Acid Naugard 445 N-550 Black Nycoflex ADB 30 DOTG Diak #1 (HMDC) Total phr Off-Gas Concentrations Ethanol Acetone t-Butanol Benzene Aniline alpha Methyl Styrene o-Toluidine
PHR 100 1 0.5 2 2 70 20 4 1.5 201
Function Terpolymer Release agent Release agent Release agent Anti-oxidant Carbon black Plasticizer Accelerator Curative Wt. Percent 0.1940 0.0004 0.0022 0.0005 0.0014 0.0081 0.0860
The allowable employee exposure level for these chemicals is different in the various regions throughout the world. Please consult local regulations in order to ensure compliance.
Ortho-Toluidine (O-Toluidine)
There are two possible sources of O-Toluidine for a compound that uses the accelerator DOTG. The O-Toluidine may be present at low levels in the DOTG itself. The O-Toluidine is also a decomposition product from the DOTG at temperatures typically used in the molding presses and post cure ovens. O-Toluidine (CAS 95-53-4) is classified as carcinogen by IARC, NTP, OSHA and ACGIH. Please consult the MSDS for DOTG and O-Toluidine to ensure proper handling of these materials. A qualitative study was run on a compound made from Vamac that contained DOTG to observe O-Toluidine levels. Head Space-GC/MS (gas chromatography/mass spectroscopy) was run on samples after a simulated press cure (5 minutes at 177 C) and after a simulated post cure (4 hours at 177 C). Trace levels of O-Toluidine were measured after the press cure simulation and higher levels were observed after the post cure simulation. A biological monitoring study was conducted on workers at two rubber plants in Germany and the study observed levels of O-Toluidine in the air as well as in blood and urine samples of the workers [Aromatic Amines in the Rubber Industry Biological Monitoring and Biochemical Monitoring, T. Weiss, G. Korinth, H. Drexler, J. Angerer, 2005]. The study suggests that skin is the primary route of incorporation of O-Toluidine for accelerators (e.g. DOTG) that may release O-Toluidine. Customers and processors using
3
accelerators that may release O-Toluidine should evaluate the study and refer to industrial hygiene regulatory standards applicable to their workplace and consider whether additional precautions may be necessary to protect workers handling accelerators against overexposure via skin. Some of the other accelerators used in compounds made from Vamac are based on Diazobicyclo Undecene (DBU). A commercially available accelerator that uses DBU is Vulcofac ACT 55. A compound containing Vulcofac ACT 55 as the accelerator in place of the DOTG was included in the Headspace GC/MS study. No O-Toluidine was observed in the off gases from either the simulated press cure or simulated post cure steps.
Thermal Decomposition Products at Elevated Temperatures
If DuPont Vamac polymers are subjected to abnormally high temperatures (about 316 C or 600 F and above), decomposition products derived from random cleavage and oxidation of the polymer can be obtained. Such temperatures can occur in a fire or during exposure to an unusual heat source. Some of the major decomposition products identified by gas chromatography mass spectroscopy include: methanol, ethanol, acetone, dimethyl formal, ethyl acetate, the carboxylic acids: acrylic, propionic, methacrylic, butanoic, pentanoic, hexanoic, undecanoic and corresponding methyl esters.
Compounding Ingredients
For information and recommendations on the safe handling of curatives and other compounding ingredients used in formulations of Vamac, contact the suppliers of those materials.
Waste Disposal
Material Safety Data Sheets (MSDS) describing proper waste disposal of DuPont materials are available on request.
Proprietary Materials
Sources of compounding ingredients mentioned in this bulletin are given below. Comparable materials from other suppliers may give equally satisfactory results.
Physical Form
Vamac ethylene acrylic elastomers are supplied in the form of bales, wrapped in either EMA fluxible wrap or PE strippable wrap. The clear fluxible wrap need not be removed from the bale as it is intended to melt into the compound during mixing. The blue strippable wrap must be completely removed from the bale prior to processing to avoid potential contamination of the compound. It is important to ensure that no remaining fragments of blue strippable wrap remain adhered to or caught up in the folds of the polymer prior to mixing.
Material Vamac
Composition Ethylene/Acrylic Elastomer Hexamethylene Diamine Carbamate Di-o-Tolyl Guanidine
Supplier DuPont Wilmington, DE DuPont Wilmington, DE Sovereign Chemical Akron, OH Akzo Nobel Chemicals Chicago, IL R. T. Vanderbilt Co. Inc. Norwalk, CT Chemtura Middlebury, CT Engineered Carbons Borger, TX Safic-Alcan Paris, France Safic-Alcan Paris, France
Diak No. 1 DOTG Armeen 18D Vanfre VAM Naugard 445 N-550 Nycoflex ADB 30 Vulcofac ACT 55
Octadecyl Amine Complex Organic Phosphate Ester Acid 4,4-Bis-(,a,a-Dimethylbenzyl) Diphenylamine Carbon Black Plasticizer Accelerator
This page intentionally left blank.
Visit us at vamac.dupont.com Contact DuPont at the following regional locations:
North America +800-222-8377 Greater China +86-400-8851-888 Latin America +0800 17 17 15 ASEAN +65-6586-3688 Europe, Middle East, Africa +41 22 717 51 11 Japan +81-3-5521-8484
The information set forth herein is furnished free of charge and is based on technical data that DuPont believes to be reliable and falls within the normal range of properties. It is intended for use by persons having technical skill, at their own discretion and risk. This data should not be used to establish specification limits nor used alone as the basis of design. Handling precaution information is given with the understanding that those using it will satisfy themselves that their particular conditions of use present no health or safety hazards. Since conditions of product use and disposal are outside our control, we make no warranties, express or implied, and assume no liability in connection with any use of this information. As with any product, evaluation under end-use conditions prior to specification is essential. Nothing herein is to be taken as a license to operate or a recommendation to infringe on patents. Caution: Do not use in medical applications involving permanent implantation in the human body. For other medical applications, discuss with your DuPont customer service representative and read Medical Caution Statement H-50103-3. Copyright 2012 DuPont. The DuPont Oval Logo, DuPont, The miracles of science, and Vamac are trademarks or registered trademarks of E.I. du Pont de Nemours and Company or its affiliates. All rights reserved. (11/06) Reference No. VME-A10628-00-D0212
Material Safety Data Sheet
VAMAC G ethylene acrylic elastomer
Version 3.3 Revision Date 07/10/2013 Ref. 130000022224
CERCLA Reportable Quantity
: 66,711 lbs Based on the percentage composition of this chemical in the product.: Methyl acrylate : WARNING! This product contains a chemical known to the State of California to cause birth defects or other reproductive harm. : Substances on the Pennsylvania Hazardous Substances List present at a concentration of 1% or more (0.01% for Special Hazardous Substances): None known.
California Prop. 65
PA Right to Know Regulated Chemical(s)
NJ Right to Know Regulated Chemical(s)
: Substances on the New Jersey Workplace Hazardous Substance List present at a concentration of 1% or more (0.1% for substances identified as carcinogens, mutagens or teratogens): None known.
SECTION 16. OTHER INFORMATION Restrictions for use : Do not use DuPont materials in medical applications involving implantation in the human body or contact with internal body fluids or tissues unless the material has been provided from DuPont under a written contract that is consistent with DuPont policy regarding medical applications and expressly acknowledges the contemplated use. For further information, please contact your DuPont representative. You may also request a copy of the DuPont POLICY Regarding Medical Applications H-50103-3 and DuPont CAUTION Regarding Medical Applications H-50102-3.
VAMAC is a Registered Trademark of E.I. du Pont de Nemours and Company. The information provided in this Safety Data Sheet is correct to the best of our knowledge, information and belief at the date of its publication. The information given is designed only as a guidance for safe handling, use, processing, storage, transportation, disposal and release and is not to be considered a warranty or quality specification. The information relates only to the specific material designated and may not be valid for such material used in combination with any other materials or in any process, unless specified in the text. Significant change from previous version is denoted with a double bar.
11 / 11